SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Inovios FDA approval of competing RRP treatment Voceryq has put Precigens PAPZIMEOS in focus, with traders debating whether the new entrant will erode its sales. Bears see a direct competitive threat, while bulls point to PAPZIMEOS full approval and commercial head start and question Inovios ability to commercialize an accelerated-approval drug.

Compound (COMP) is a cryptocurrency and operates on the Ethereum platform. Compound has a current supply of 10,000,000 with 9,999,999.99995246 in circulation. The last known price of Compound is 20.49527411 USD and is down -2.02 over the last 24 hours. It is currently trading on 652 active market(s) with $25,001,434.49 traded over the last 24 hours. More information can be found at https://www.compound.xyz/.

Compound

Discussion centers on Compounds institutional-market launch and treasury-backed institutional finance push, which traders view as a potential catalyst alongside the protocols planned upgrades. Optimism about COMPs limited supply and a possible breakout is tempered by complaints that it continues to lag other crypto assets.

Spotify Technology SA engages in the provision of digital music services. It operates through the Premium and Ad-Supported segments. The Premium segment provides subscribers with online and offline streaming access of music and podcasts on computers, tablets, and mobile devices. The Ad-Supported segment offers users with limited on-demand online access of music and unlimited online access of podcasts on computers, tablets, and mobile and smart devices. The company was founded by Daniel Ek and Martin Lorentzon on December 27, 2006 and is headquartered in Stockholm, Sweden.

Spotify Technology S.A.

Spotifys Q3 report and stronger-than-expected Q4 profit outlook are driving attention, with shares rising despite revenue and EPS misses. Traders are focused on subscriber growth and improved margins, while some question the rally given the earnings shortfall and higher expenses.

Twilio, Inc. engages in the development of communications software, cloud-based platforms, and services. It operates through Twilio Communications and Twilio Segments. The Twilio Communications segment includes the platforms Messaging and Voice. The Twilio Segment involves Segment, Engage, Flex, Email, and others. The company was founded by John Wolthuis, Jeffery G. Lawson, and Evan Cooke in March 2008 and is headquartered in San Francisco, CA.

Twilio Inc - Ordinary Shares Class A

Twilio Inc

Twilios shares sold off despite a quarterly earnings beat as its outlook signaled slower organic growth, prompting concerns about deceleration and softer guidance. Traders are split between viewing the drop as an overreaction and buy-the-dip opportunity, and seeing the slower outlook as outweighing the results; some remain positive on Twilios longer-term AI communications potential.

iShares Trust - iShares China Large-Cap ETF

iShares China Large-Cap ETF

FXI is drawing attention amid a broad selloff in Chinese equities, with traders citing the CSI 300s bear-market decline, weak domestic demand and added uncertainty around AI export restrictions. The community is divided between warnings of a prolonged downturn and views that beaten-down China shares may be nearing a base.

Zebec Network (ZBCN) is a cryptocurrency launched in 2022and operates on the Solana platform. Zebec Network has a current supply of 99,998,768,617.445403. The last known price of Zebec Network is 0.00204055 USD and is down -0.09 over the last 24 hours. It is currently trading on 133 active market(s) with $10,537,951.06 traded over the last 24 hours. More information can be found at https://zebec.io/.

Zebec Network

Attention is centered on Zebecs payroll and payments integrations, particularly the MoneyGram/Stellar connection and a reported Germany/AllUnity deployment, which bullish traders view as adoption catalysts. Skeptics counter that partnership news has yet to translate into sustained token demand or price strength, while speculation about additional Robinhood or Ripple links remains unconfirmed.

OpenAI

OpenAIs potential IPO is driving attention, with traders debating reports that the listing could slip to 2027 amid market volatility and heightened safety and legal scrutiny. The discussion is split between enthusiasm for a major AI listing and skepticism about OpenAIs valuation, cash burn, and ability to sustain growth against competitors.

Artificial Superintelligence Alliance (FET) is a cryptocurrency launched in 2018. Artificial Superintelligence Alliance has a current supply of 2,714,384,546.672 with 2,419,135,848.3909366 in circulation. The last known price of Artificial Superintelligence Alliance is 0.16707757 USD and is up 1.84 over the last 24 hours. It is currently trading on 592 active market(s) with $193,186,396.23 traded over the last 24 hours. More information can be found at https://superintelligence.io/.

Fetch.ai

FETs price action and its place in the AI-crypto trade dominate the discussion, with traders watching for a breakout and describing relative strength during broader market weakness. Bullish dip-buying and accumulation hopes coexist with frustration over lagging performance and concern that Bitcoin weakness could weigh on the token.

Invesco Exchange-Traded Fund Trust - Invesco S&P 500 Equal Weight ETF

Invesco S&P 500 Equal Weight ETF

RSP is drawing attention as a gauge of whether the S&P 500 rally is broadening beyond mega-cap tech, with traders highlighting its relative strength and recent highs as evidence of rotation into the average stock. Others warn that participation remains uneven and question whether the rotation can persist, especially as technology leadership shifts.

Crocs, Inc. engages in the design, development, manufacture, worldwide marketing, sale, and distribution of lifestyle footwear and accessories. It operates through the Crocs Brand and HEYDUDE Brand segments. The Crocs Brand segment refers to the United States, South Korea, China, Japan, Singapore, Canada, Germany, Great Britain, France, Malaysia, Australia, Puerto Rico, the Netherlands, Australia, India, and Ireland. The HEYDUDE Brand segment focuses on the United States. The company was founded by Scott Seamans, George B. Boedecker, Jr., and Lyndon V. Hanson III in 2002 and is headquartered in Broomfield, CO.

Crocs Inc

Crocs is drawing attention after quarterly results topped expectations and management raised its outlook, citing a continuing HEYDUDE recovery and steady demand for its core brand; the news fueled a sharp rally. Traders are cheering the breakout, while others warn of profit-taking and point to continued weakness in North American sales.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

S&P 500, Nasdaq And Dow Close At Record Highs Amid Positive Reports Of US-Iran Ceasefire Negotiations —  IBM, SNOW, CZR, AKTX, LLY In Focus

Equity

U.S. and Iranian negotiators agreed on a 60-day memorandum of understanding to extend the ceasefire, media reports suggested.

AKTX Stock Shoots 50% Higher To Head Toward Best Month In Nearly 11 Years – What’s Fueling This Super Rally?

Akari Therapeutics’ CEO Abizer Gaslightwala highlighted the potential of the company’s proprietary platform to treat cancer ahead of ASCO 2026.

VNET Group, Akari Therapeutics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

US stock futures up, VNET Group shares down 3.8% after reporting Q1 loss of $(1.20) per share on $390.133 million sales. Other stocks also fall.read more...

Why Akari Therapeutics Stock Is Falling On Tuesday?

Discover why Akari Therapeutics PLC (NASDAQ: AKTX) stock is falling on Tuesday after last week's massive 255% rally on positive preclinical cancer data.read more...

Akari Therapeutics Stock Jumps On Promising Preclinical Data

Akari Therapeutics shares are surging after preclinical data showed AKTX101 synergized with KRAS inhibition in pancreatic cancer models.read more...

This Emerging Biotech Wave Could Create the Next Monster Healthcare Winners

The biotechnology sector continues attracting speculative capital as investors aggressively position around next-generation oncology, metabolic disease, and CNS therapy platforms. Artificial intelligence, precision medicine, RNA biology, and novel drug delivery technologies are rapidly reshaping how Wall Street evaluates emerging healthcare companies. As larger pharmaceutical companies race to secure pipeline assets and differentiated platforms, smaller clinical-stage companies with compelling preclinical or clinical data are increasingly finding themselves under the spotlight. $AKTX, $NTHI, $MTVA, $HCWB, $BAC, $STT, $BCS

AKTX Stock Goes Parabolic After Hours On $5.5M Capital Raise, Cancer Data Win: Wall Street Sees 400% Upside 

Akari said its experimental therapy AKTX-101 showed strong results when paired with an already-approved cancer drug in lab tests on pancreatic cancer cells that carry a common KRAS mutation.


The Biotech Repricing Wave May Be Starting as Capital Pours into High-Impact Oncology Platforms

Biotech investors are once again rotating aggressively into clinical-stage growth stories as a fresh wave of capital raises, pipeline expansions, analyst initiations, and oncology breakthroughs reshapes momentum across the sector. $NTHI, $IMMX, $RLAY, $AKTX, $LIMN

Why Akari Therapeutics Stock Is Surging On Thursday?

Akari Therapeutics PLC (NASDAQ:AKTX) sees stock growth fueled by Q1 2026 earnings optimism and a new European patent for its PH1 ADC payload.read more...

This account has been verified as an official AKTX representative.

Verified Account

Akari Therapeutics

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company. It engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. The company was founded on October 7, 2004 and is headquartered in Tampa, FL.

Akari Therapeutics Plc - ADR

Bearish Sentiment

<ul class="summary-bullets"><li>The S&amp;P 500 rose 0.6%, and the Dow Jones gained 0.1%, while the Nasdaq 100 added 0.6%.</li><li>Oil prices and Treasury yields eased as investors hoped for a longer-lasting ceasefire agreement.&nbsp;</li><li>Consumer spending, adjusted for inflation, increased 0.1% in April after rising 1.6% in March.</li></ul><p>U.S. benchmark stock indices ended at record highs on Thursday as signs of easing U.S.-Iran tensions aided sentiment.&nbsp;</p><p>The&nbsp;<a href="https://stocktwits.com/symbol/SPX">S&amp;P 500</a> ended 0.6% higher, the&nbsp;<a href="https://stocktwits.com/symbol/NDX">Nasdaq</a> 100 rose 0.8%, and the&nbsp;<a href="https://stocktwits.com/symbol/DJI">Dow Jones</a> inched 0.1% higher, all hitting record highs, as per data from Koyfin. The Russell 2000, which tracks stocks with small market capitalization, gained for the sixth session and hit record highs on Thursday.&nbsp;</p><p>Among ETFs tracking benchmark indexes, the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF (SPY)</a> and&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust&nbsp;</a>(QQQ) ended Thursday around 0.6 and 1% higher respectively. The&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF Trust</a> (DIA) gained 0.1%.&nbsp;</p><p>The VanEck Semiconductor ETF (<a href="https://stocktwits.com/symbol/SMH">SMH</a>) rose 1%.&nbsp;</p><p>Meanwhile, retail sentiment on Stocktwits for SPY, QQQ and DIA was all in the “extremely bullish” territory with “extremely high” message volumes.&nbsp;&nbsp;</p><h2 class="st-heading-2"><strong>US Market Drivers</strong></h2><div><figure class="table"><table class="ck-table-resized"><colgroup><col><col><col></colgroup><tbody><tr><td>Index</td><td>Move</td><td>Close</td></tr><tr><td>Dow Jones Industrial Average</td><td>0.1%</td><td>50,668.97&nbsp;</td></tr><tr><td>S&amp;P 500</td><td>0.6%</td><td>7,563.63&nbsp;</td></tr><tr><td>Nasdaq 100</td><td>0.6%</td><td>30,223.89&nbsp;</td></tr></tbody></table></figure></div><p>U.S. equities hit new highs following a report from Axios, citing a regional source and two U.S. officials, stating that Iranian and U.S. negotiators have reached a 60-day memorandum of understanding. This agreement aims to prolong the ceasefire and facilitate additional discussions regarding Iran’s nuclear capabilities. The&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.axios.com/2026/05/28/iran-peace-deal-trump-approval">report</a> noted, however, that the deal is still awaiting final authorization from President Donald Trump.</p><p>“The market has been expecting some type of MOU — memorandum of understanding — here,” said David Wagner, head of equities at Aptus Capital Advisors told CNBC in an interview. “You’re going to see the discretionary names run as a first knee-jerk reaction to a lot of this news, which can drive the market higher.”&nbsp;</p><p>However, Treasury Secretary Scott Bessent said on Thursday that no Iranian sanctions would be lifted unless the country gives up its enriched uranium stockpile.&nbsp;</p><p>Oil prices pulled back from their highs following the report. The West Texas Intermediate crude oil futures was last trading at around $89 a barrel, while Brent futures traded around $94 a barrel, as per data from CNBC.&nbsp;</p><p>Moreover, the Personal Consumption Expenditures (PCE) Index, which is the Federal Reserve’s preferred gauge of inflation, advanced 3.8% in April on an annualized basis.</p><p>The Commerce Department data showed that core PCE, which excludes food and energy, rose 3.3% on an annualized basis in April, up 0.2% on a monthly basis.</p><h2 class="st-heading-2"><strong>Trending Stocks To Watch&nbsp;</strong></h2><p>International Business Machines (<a href="https://stocktwits.com/symbol/IBM">IBM</a>): The firm unveiled an aggressive plan to spend more than $10 billion over the next five years on quantum computing, aiming to bring a commercial, large-scale system to market by 2029.</p><p>Snowflake (<a href="https://stocktwits.com/symbol/SNOW">SNOW</a>):&nbsp; Blockbuster first-quarter results and a massive $6 billion partnership with Amazon Web Services fueled bullish calls for as much as 85% upside ahead.&nbsp;&nbsp;</p><p>Eli Lilly (<a href="https://stocktwits.com/symbol/LLY">LLY</a>): Shares hit record highs after CVS Health (CVS) said it will restore coverage of Lilly’s weight-loss injection Zepbound and begin covering its newly approved obesity pill, Foundayo.&nbsp;</p><p>Akari Therapeutics (<a href="https://stocktwits.com/symbol/AKTX">AKTX</a>): CEO Abizer Gaslightwala highlighted the potential of the company’s proprietary antibody drug conjugate platform to treat cancer, ahead of a key oncology conference.&nbsp;</p><p>Caesars Entertainment (<a href="https://stocktwits.com/symbol/CZX">CZX</a>): Entered into a definitive agreement to be acquired by Fertitta Entertainment Inc. in an all-cash deal valued at about $17.6 billion.&nbsp;</p><p>Read More: <a href="https://stocktwits.com/news-articles/markets/equity/hood-stock-jumps-to-best-day-this-month-on-trump-accounts-app-launch/cZgish3RetI">HOOD Stock Jumps To Best Day This Month On Trump Accounts App Launch</a></p><p>For updates and corrections, email newsroom[at]stocktwits[dot]com.</p>

A laptop keyboard, a reflected illustrative stock graph displayed on a screen and the Nasdaq logo. (Photo by Jakub Porzycki/NurPhoto via Getty Images)

Caesars Entertainment Inc

Dow Jones Industrial Index

International Business Machines Corp.

Lilly(Eli) & Co

Nasdaq-100 Index

VanEck Semiconductor ETF

Snowflake Inc

S&P 500 Index

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$8.24
Prev Close	$8.00
Open	$8.50
Dividend Yield	0.00%
50-Day Moving Average	$9.28
Beta	0.73
Avg. Volume	81,405.42
PE Ratio	-0.03

52-Week High	$33.60
52-Week Low	$3.02
Market Capitalization	$14.42M
EPS (Annual)	N/A
Price to Book	0.78
Revenue Per Employee	$0.00

Feed

News

Sentiment

Fundamentals

Info

AKTX Fundamentals